Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...
Chris Hemsworth's new documentary, "A Road Trip to Remember," takes viewers on a motorbike adventure around Melbourne and Australia's Northern Territory. His costar and father, 71-year-old Craig ...
An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.
Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...
Mark Pappas, who founded popular seafood restaurants including the iconic Pappas Restaurant & Sports Bar, died Sunday at 93.
Shares of Novo Nordisk ( NVO 5.58%) fell on Monday, finishing down 5.6%. The drop comes as the S&P 500 and the Nasdaq ...
Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...
Novo Nordisk A/S’ wild card bet that its GLP-1 receptor agonist semaglutide could be used to treat Alzheimer’s disease has ...
The biomarker improvements in the EVOKE studies are worth noting, observed Howard Fillit, MD, of the Alzheimer's Drug ...
There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular ...
As a constituent in Georgia 14th Congressional District, I would like to bring awareness to the recently introduced H.R. 6130 The Alzheimer’s Screening and Prevention (ASAP) Act . This legislation ...
Investor's Business Daily on MSN
Novo Dives After Weight-Loss Pill Fails In Alzheimer's Disease; Biogen Jumps
Novo Nordisk stock toppled Monday after its weight-loss pill failed to significantly slow the progression of Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results